4月15日 - ** 金斯瑞生物科技1548.HK股价攀升4.5%至13.27港元，有望创下自4月1日以来的最大单日百分比涨幅
** 股价在连续第二个交易日上涨中创下自4月9日以来的最高水平
** 金斯瑞称其联营公司传奇生物LEGN.O (link) 宣布，在截至2026年3月的季度里，血液癌症药物CARVYKTI产生了约5.97亿美元的净贸易销售额。
** 年初至今，金斯瑞港股上涨6.2%，恒生生物科技指数.HSBIO上涨11.9%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.